BioInvent International AB logo

BioInvent International AB

BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.

139 employees · est. 1983 · Lund, Sweden

VS
Eureka Therapeutics, Inc logo

Eureka Therapeutics, Inc

45 employees · est. 2006 · Emeryville, United States

BioInvent International AB is the older company (1983 vs 2006); BioInvent International AB is the larger of the two.

Side-by-Side Comparison

BioInvent International AB Eureka Therapeutics, Inc
Founded
1983 older 2006
Headquarters
Lund, Sweden Emeryville, United States
Employees
139 larger 45
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health Care, Health and Wellness
Funding Stage
IPO Grant
Total Funding
$5.64M $139.50M
Funding Rounds
6 7
Services
Antibody Discovery and Development, Clinical Programs in Immuno-oncology, Contract Manufacturing for Clinical Trials, Collaboration with Pharmaceutical Companies Not tracked yet
Target Customers
Cancer Patients, Biotech and Pharmaceutical Companies, Medical Professionals, Clinical Researchers Not tracked yet
Taxonomy
Immuno-Oncology, Antibody Drug Development, Hematological Cancer Therapy, Solid Tumor Therapy, F.I.R.S.T™ Technology Platform, N-CoDeR™ Antibody Library, Clinical-Stage Biotech, Research Collaborations, License Agreements, Antibody Manufacturing, Process Development, Antibody Drug Discovery, Co-Development Agreements, Proprietary Antibody Selection Immunotherapy, Cancer Treatment, Antibody Drug Discovery, Tumor Antigens, Phage Display, Cell Therapy, Oncology, Intracellular Targets, Novel Antibody Immunotherapies
Website
bioinvent.com eurekatherapeutics.com
BioInvent International AB logo

About BioInvent International AB

BioInvent International AB, a clinical-stage biotech firm founded in 1983 and headquartered in Sweden, is pioneering the landscape of immuno-oncology therapies by translating cancer antibody biology into innovative treatments. Leveraging its unique F.I.R.S.T™ technology platform, the company is at t...

Eureka Therapeutics, Inc logo

About Eureka Therapeutics, Inc

Eureka Therapeutics, Inc. is a biotechnology company based in the San Francisco Bay Area, focusing on revolutionary immunotherapies for cancer treatment. Utilizing antibody drug discovery and engineering technologies, the company is advancing safe and effective therapies for targeting previously ina...

We will tell you when either one moves

BounceWatch watches BioInvent International AB and Eureka Therapeutics, Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioInvent Internationa... and Eureka Therapeutics, I... — by email.

Frequently Asked Questions

BioInvent International AB — BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.. Eureka Therapeutics, Inc. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioInvent International AB has raised $5.64M while Eureka Therapeutics, Inc has raised $139.50M.
BioInvent International AB and Eureka Therapeutics, Inc operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioInvent International AB with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at BioInvent International AB on 15 Jun 2026, and Eureka Therapeutics, Inc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes